WA Parsonage

Human heart beta-adrenoceptors: beta(1)-adrenoceptor diversification through 'affinity states' and polymorphism (2007)

Molenaar, P, Chen, L, Semmler, ABT, Parsonage, WA, Kaumann, AJ

In atrium and ventricle from failing and non-failing human hearts, activation of beta(1)- or beta(2)-adrenoceptors causes increases in contractile force, hastening of relaxation, protein kinase...

Fundamental considerations of beta-adrenoceptor subtypes in human heart failure (2005)

Molenaar, P, Parsonage, WA

beta-Adrenoceptor antagonists have revolutionized the management of heart failure in humans. However, fundamental questions remain concerning their use. Currently, there is considerable debate about...

Fundamental considerations of beta-adrenoceptor subtypes in human heart failure (2005)

Molenaar, P, Parsonage, WA

beta-Adrenoceptor antagonists have revolutionized the management of heart failure in humans. However, fundamental questions remain concerning their use. Currently, there is considerable debate about...

Fundamental considerations of beta-adrenoceptor subtypes in human heart failure

Molenaar, P, Parsonage, WA

beta-Adrenoceptor antagonists have revolutionized the management of heart failure in humans. However, fundamental questions remain concerning their use. Currently, there is considerable debate about...

Cardiac implications for the use of beta(2)-adrenoceptor agonists for the management of muscle wasting

Molenaar, P, Chen, L, Parsonage, WA

There are proposals for the implementation of beta(2)-adrenoceptor agonists for the management of muscle wasting diseases. The idea has been initiated by studies in animal models which show that...